Table 1:
Baseline characteristics of 121 patients treated using physician-modified endografting for pararenal aortic aneurysm and thoraco-abdominal aortic aneurysm.
| Variable | All patients (n = 121) | PRAA (n = 62) | TAAA (n = 59) | P-value |
|---|---|---|---|---|
| Age (years) | 75.6 ± 7.63 | 77.1 ± 7.74 | 74.0 ± 7.23 | 0.022 |
| Male sex | 100 (82.6) | 56 (90.3) | 44 (74.6) | 0.024 |
| Hypertension | 114 (94.2) | 58 (93.5) | 56 (94.9) | 0.749 |
| Diabetes mellitus | 21 (17.4) | 12 (19.4) | 9 (15.3) | 0.555 |
| Dyslipidaemia | 60 (49.6) | 29 (46.8) | 31 (52.5) | 0.530 |
| Coronary artery disease | 39 (32.2) | 24 (38.7) | 15 (25.4) | 0.119 |
| Cerebrovascular disease | 28 (23.1) | 13 (21.0) | 15 (25.4) | 0.566 |
| Peripheral artery disease | 19 (15.7) | 9 (14.5) | 10 (16.9) | 0.716 |
| COPD | 45 (37.2) | 22 (35.5) | 23 (39.0) | 0.694 |
| CKD (eGFR < 59) | 62 (51.2) | 31 (50.0) | 31 (52.5) | 0.782 |
| Smoking | 90 (74.4) | 45 (72.6) | 45 (76.3) | 0.645 |
| Antithrombotic therapy | 81 (66.9) | 45 (72.6) | 36 (61.0) | 0.252 |
| Previous aortic surgery | 36 (29.8) | 14 (22.6) | 22 (37.3) | 0.079 |
| ASA score ≥ 3 | 77 (63.6) | 36 (58.1) | 41 (69.5) | 0.448 |
| Maximum–minimum diameter of aneurysm (mm) | 57.9 ± 12.7 | 55.9 ± 11.9 | 60.1 ± 13.2 | 0.069 |
| Rupture | 18 (14.9) | 7 (11.3) | 11 (18.6) | 0.262 |
Continuous variables are presented as mean ± standard deviation and categorical variables as number of patients (%).
ASA: American Society of Anesthesiologists; CKD: chronic kidney disease; COPD: chronic obstructive pulmonary disease; eGFR: estimated glomerular filtration rate; PRAA: pararenal aortic aneurysm; TAAA: thoraco-abdominal aortic aneurysm.